This inventor holds 1 USPTO granted patent. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Kotakonda Shailaja: Innovator in Heterocyclic Compound Synthesis
Introduction
Kotakonda Shailaja is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of chemistry, particularly in the synthesis of heterocyclic compounds. His innovative work has implications for the treatment of inflammatory and immune disorders.
Latest Patents
Shailaja holds a patent for a method of synthesizing diaryl-substituted heterocyclic compounds, including tetrahydrofurans. This method provides a way to synthesize 2,5-diaryl-substituted tetrahydrofurans and tetrahydrothiophenes. The patent also includes methods for synthesizing starting materials and intermediates. An important application of this invention is in the synthesis of CMI-392, a highly effective agent for treating various medical conditions.
Career Highlights
Shailaja is associated with Millennium Pharmaceuticals Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in pharmaceuticals and therapeutic agents.
Collaborations
He has collaborated with notable colleagues, including Alla Venkata Rama Rao and Mukund Shankar Chorghade, to further enhance his research initiatives.
Conclusion
Kotakonda Shailaja's contributions to the field of chemistry, particularly in the synthesis of heterocyclic compounds, highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile